Zobrazeno 1 - 10
of 813
pro vyhledávání: '"Burtrum D"'
Autor:
Kotanides H; Lilly Research Laboratories, Eli Lilly and Company, New York, New York. helen.kotanides@lilly.com., Sattler RM; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Lebron MB; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Carpenito C; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Shen J; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Li J; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Surguladze D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Haidar JN; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Burns C; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Shen L; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Inigo I; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Pennello AL; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Forest A; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Chen X; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Chin D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Sonyi A; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Topper M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Boucher L; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Sharma P; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Zhang Y; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Burtrum D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Novosiadly RD; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Ludwig DL; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Plowman GD; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Kalos M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2020 Apr; Vol. 19 (4), pp. 988-998.
Autor:
Li Y; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA. yiwen.li@lilly.com.; Eli Lilly and Company, 450 East 29th Street, New York, NY, 10016, USA. yiwen.li@lilly.com., Carpenito C; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Wang G; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Surguladze D; Lilly Research Laboratories, Department of Preclinical Pharmacology, New York, NY, USA., Forest A; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Malabunga M; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Murphy M; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Zhang Y; Lilly Research Laboratories, Department of Biologics Technology, New York, NY, USA., Sonyi A; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Chin D; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Burtrum D; Lilly Research Laboratories, Department of Biologics Technology, New York, NY, USA., Inigo I; Lilly Research Laboratories, Department of Preclinical Pharmacology, New York, NY, USA., Pennello A; Lilly Research Laboratories, Department of Preclinical Pharmacology, New York, NY, USA., Shen L; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Malherbe L; Lilly Research Laboratories, Department of Non-Clinical Safety, Indianapolis, IN, USA., Chen X; Lilly Research Laboratories, Department of Quantitative Biology, New York, NY, USA., Hall G; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Haidar JN; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Ludwig DL; Lilly Research Laboratories, Department of Biologics Technology, New York, NY, USA., Novosiadly RD; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Kalos M; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA. MKALOS@ITS.JNJ.COM.; Eli Lilly and Company, 450 East 29th Street, New York, NY, 10016, USA. MKALOS@ITS.JNJ.COM.; Janssen Pharmaceutical Companies of Johnson and Johnson, Springhouse, PA, USA. MKALOS@ITS.JNJ.COM.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Jun 04; Vol. 6 (1), pp. 45. Date of Electronic Publication: 2018 Jun 04.
Autor:
Li Y; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA yiwen.li@lilly.com.; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street 10016 New York NY USA., Carpenito C; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Wang G; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Surguladze D; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Preclinical Pharmacology New York NY USA., Forest A; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Malabunga M; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Murphy M; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Zhang Y; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Biologics Technology New York NY USA., Sonyi A; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Chin D; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Burtrum D; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Biologics Technology New York NY USA., Inigo I; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Preclinical Pharmacology New York NY USA., Pennello A; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Preclinical Pharmacology New York NY USA., Shen L; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Malherbe L; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Non-Clinical Safety Indianapolis IN USA., Chen X; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Quantitative Biology New York NY USA., Hall G; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Haidar JN; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Ludwig DL; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Biologics Technology New York NY USA., Novosiadly RD; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Kalos M; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA MKALOS@ITS.JNJ.COM.; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street 10016 New York NY USA.; grid.430674.2Janssen Pharmaceutical Companies of Johnson and Johnson Springhouse PA USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Apr 30; Vol. 6 (1), pp. 31. Date of Electronic Publication: 2018 Apr 30.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shen Y; a Antibody Technology; Eli Lilly and Company ; New York , NY USA., Zeng L, Novosyadlyy R, Forest A, Zhu A, Korytko A, Zhang H, Eastman SW, Topper M, Hindi S, Covino N, Persaud K, Kang Y, Burtrum D, Surguladze D, Prewett M, Chintharlapalli S, Wroblewski VJ, Shen J, Balderes P, Zhu Z, Snavely M, Ludwig DL
Publikováno v:
MAbs [MAbs] 2015; Vol. 7 (5), pp. 931-45.
Autor:
Kim, Taehoon1 (AUTHOR), Lim, Hyeonseob1 (AUTHOR), Jun, Soyeong1 (AUTHOR), Park, Junsik2 (AUTHOR), Lee, Dongin1 (AUTHOR), Lee, Ji Hyun3,4 (AUTHOR), Lee, Jung-Yun2 (AUTHOR) yodrum682@gmail.com, Bang, Duhee1 (AUTHOR) duheebang@yonsei.ac.kr
Publikováno v:
Scientific Reports. 11/22/2023, Vol. 13 Issue 1, p1-11. 11p.
Autor:
Galal, Mariam Ahmed1,2 (AUTHOR) maelsayed@alumni.alfaisal.edu, Alouch, Samhar Samer1 (AUTHOR), Alsultan, Buthainah Saad1 (AUTHOR), Dahman, Huda1 (AUTHOR), Alyabis, Nouf Abdullah1 (AUTHOR), Alammar, Sarah Ammar1 (AUTHOR), Aljada, Ahmad1 (AUTHOR) maelsayed@alumni.alfaisal.edu
Publikováno v:
International Journal of Molecular Sciences. Oct2023, Vol. 24 Issue 19, p15006. 34p.
Publikováno v:
In Growth Hormone & IGF Research 2010 20 Supplement 1:S60-S60
Autor:
Lebron MB; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Brennan L; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Damoci CB; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Prewett MC; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., O'Mahony M; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Duignan IJ; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Credille KM; Eli Lilly and Company; Indianapolis, IN USA., DeLigio JT; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Starodubtseva M; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Amatulli M; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Zhang Y; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Schwartz KD; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Burtrum D; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Balderes P; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Persaud K; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Surguladze D; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Loizos N; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Paz K; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA., Kotanides H; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; New York, NY USA.
Publikováno v:
Cancer biology & therapy [Cancer Biol Ther] 2014 Sep; Vol. 15 (9), pp. 1208-18. Date of Electronic Publication: 2014 Jun 12.